Drug Profile
Research programme: dengue virus vaccine - Cyto Pulse/WRAIR
Alternative Names: Dengue virus vaccine research programme - Cyto Pulse/WRAIRLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Cyto Pulse Sciences; Walter Reed Army Institute of Research
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Dengue
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Dengue in USA (Injection)
- 16 Aug 2006 Cyto Pulse has been awarded a $US2 million grant from the US NIH for the development of a DNA vaccine against Flaviviruses and DNA vaccine delivery system
- 26 Sep 2005 Preclinical trials in Dengue in USA (Injection)